HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative double-blind study of tiaprofenic acid versus piroxicam in the treatment of osteoarthritis of the knee.

Abstract
A double-blind, parallel-group study was carried out to compare the clinical efficacy and tolerance of tiaprofenic acid and piroxicam in 80 patients suffering from osteoarthritis of the knee. Tiaprofenic acid was administered orally at a dosage of 900 mg daily for 14 days and piroxicam at a dosage of 40 mg daily. The following parameters were assessed: spontaneous morning pain; spontaneous night pain; pain during walking; pain on passive mobilisation; pain on squatting; morning stiffness; duration of morning stiffness; local inflammatory signs; and overall mobility of the joint. All these parameters were evaluated before treatment started and at days 7 and 14. At the end of the study, the physician made an overall assessment, and the results were statistically evaluated. The results showed that in both groups of patients, the signs and symptoms improved significantly from the seventh day of the trial, but there were no significant differences between the 2 groups for any of the assessed parameters. However, the physician's overall assessment was in favour of tiaprofenic acid due to a greater number of important improvements.
AuthorsA Maccagno, O Sebastian, E Di Giorgio
JournalDrugs (Drugs) Vol. 35 Suppl 1 Pg. 64-7 ( 1988) ISSN: 0012-6667 [Print] New Zealand
PMID3282868 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Propionates
  • Piroxicam
  • tiaprofenic acid
Topics
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Knee Joint
  • Male
  • Middle Aged
  • Osteoarthritis (drug therapy)
  • Piroxicam (administration & dosage, adverse effects, therapeutic use)
  • Propionates (administration & dosage, adverse effects, therapeutic use)
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: